Comunicati Stampa
Salute e Benessere
Salute e Benessere
Record first-quarter revenue of €239 million, reflecting 14% topline growth
Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2025 – 7:00 AM CET Record first-quarter revenue of €239 million, reflecting 14% topline growthFagron, the leading global player in pharmaceutical compounding, today publishes its quarterly results for the period ending 31 March 2025. Key Highlights Revenue maintained its strong growth momentum, increasing 14.1% on reported basis to €238.7 million (15.2% at CER), with all regions...
Rotterdam,
(informazione.news - comunicati stampa - salute e benessere)
Regulated information - inside information
Nazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2025 – 7:00 AM CET
Fagron, the leading global player in pharmaceutical compounding, today publishes its quarterly results for the period ending 31 March 2025.
”
Attachment
Per maggiori informazioni
Sito Web
fagron.com
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Non disponibili